Hearing

Notice - CORMARK SECURITIES INC., WILLIAM JEFFREY KENNEDY, MARC JUDAH BISTRICER, and SALINE INVESTMENTS LTD., File No. 2022-24

Retrieved on: 
Monday, April 8, 2024
Tribunal, Hearing

TORONTO, April 8, 2024 /CNW/ - The following merits hearing dates have changed in the above-named matter:

Key Points: 
  • TORONTO, April 8, 2024 /CNW/ - The following merits hearing dates have changed in the above-named matter:
    the previously scheduled day of April 17, 2024 will not be used for the merits hearing; and
    the hearing will continue on April 11, 12, 15, 16 and 30, 2024, May 1, 2, 3, 21, 22, 28, 29, 30 and 31, 2024, and June 3, 4, 5, 6, 10, 11, 12, 13 and 14, 2024 at 10:00 a.m. on each day.
  • The hearing will be held at the offices of the Tribunal at 20 Queen Street West, 17th floor, Toronto.
  • Members of the public may observe the hearing by videoconference, by selecting the "Register to attend" link on the Tribunal's hearing schedule, at capitalmarketstribunal.ca/en/hearing-schedule .

What Are The Experts Saying About Food Additives Ban Proposals?

Retrieved on: 
Monday, April 8, 2024
Health, Nutrition, Science, Food additive, Risk, Paranoia, Food and Drug Administration, CFS, University, Food, Doctor of Philosophy, University of Rhode Island, Health Canada, NCA, Toxicology, FDA, Food safety, Hearing, Pharmaceutical industry

This prompts the question: What are the qualified experts saying?

Key Points: 
  • This prompts the question: What are the qualified experts saying?
  • "It's time for our nation's food safety experts to flex their expertise and drive the conversation, because maintaining FDA's role as the ultimate authority and regulator in ensuring food safety is critical for our country."
  • February 16, 2024
    Institute of Food Technologists Chief Science and Technology Officer Bryan Hitchcock: "Food additives not only help improve shelf life and reduce microbiological growth but help ensure a safe and affordable food supply while also reducing food loss and waste."
  • "Usurping FDA's authority does nothing but create a state-by-state patchwork of inconsistent state requirements that increase food costs, create confusion around food safety, and erode consumer confidence in our food supply."

Alger Expands High-Conviction Growth Equity Lineup with the Launch of the Alger AI Enablers & Adopters and Alger Concentrated Equity Strategies

Retrieved on: 
Monday, April 8, 2024
Overweight, AP, BANK, Organization, Algorithm, Growth, Tax, ETF, Philosophy, EPS, FDIC, Name, Risk, Public, Terrorism, History, Class, NAV, Virginia High School League, Software, APS, Prospectus, Infection, CFA, Investment, Intellectual property, NOT, Pandemic, Artificial intelligence, Hearing, Financial adviser

NEW YORK, April 8, 2024 /PRNewswire-PRWeb/ -- Fred Alger Management, LLC ("Alger"), a privately held $25.7 billion growth equity investment manager, today announced the launch of two high-conviction portfolios: Alger AI Enablers & Adopters and Alger Concentrated Equity. Both strategies are available as ETFs, mutual funds, and separate accounts.

Key Points: 
  • NEW YORK, April 8, 2024 /PRNewswire-PRWeb/ -- Fred Alger Management, LLC ("Alger"), a privately held $25.7 billion growth equity investment manager, today announced the launch of two high-conviction portfolios: Alger AI Enablers & Adopters and Alger Concentrated Equity.
  • Alger AI Enablers & Adopters, managed by Patrick Kelly, CFA, is a focused portfolio of companies actively involved in developing and implementing Artificial Intelligence (AI) technologies.
  • In our view, organizations that embrace AI technologies better position themselves to drive sustainable growth in the digital age.
  • Alger Concentrated Equity is a focused portfolio of 20-30 stocks representing the highest conviction investment ideas of portfolio manager Dr. Ankur Crawford.

Decision Notice - CIRO Sanctions Antony Kin San Chau

Retrieved on: 
Friday, April 5, 2024
Disclosure, Investment, Hearing, CIRO, The central science, Financial adviser

The hearing panel imposed the following sanctions on Antony Kin San Chau:

Key Points: 
  • The hearing panel imposed the following sanctions on Antony Kin San Chau:
    a permanent prohibition from conducting securities related business while in the employ of or associated with any Dealer Member of CIRO, and
    Antony Kin San Chau is also required to pay costs in the amount of $6,000.
  • The Notice of Hearing and Statement of Allegations which sets out the allegations are available at:
    During the period described in the Notice of Hearing, Antony Kin San Chau conducted business in the Toronto, Ontario, area.
  • The Canadian Investment Regulatory Organization (CIRO) is the national self-regulatory organization that oversees all investment dealers, mutual fund dealers and trading activity on Canada's debt and equity marketplaces.
  • CIRO is committed to the protection of investors, providing efficient and consistent regulation, and building Canadians' trust in financial regulation and the people managing their investments.

Continuation of Sanctions Hearing in the matter of Andrew Kazina

Retrieved on: 
Friday, April 5, 2024
MB, Investment, Marketing, Exercise, Hearing, CIRO, The central science

WINNIPEG, MB, April 5, 2024 /CNW/ - A sanctions hearing was held before a hearing panel of the Canadian Investment Regulatory Organization (CIRO) under the Mutual Fund Dealer Rules in the matter of Andrew Kazina on March 20, 2024.

Key Points: 
  • WINNIPEG, MB, April 5, 2024 /CNW/ - A sanctions hearing was held before a hearing panel of the Canadian Investment Regulatory Organization (CIRO) under the Mutual Fund Dealer Rules in the matter of Andrew Kazina on March 20, 2024.
  • The sanctions hearing will continue on June 13, 2024.
  • The hearing is open to the public, unless the panel orders otherwise.
  • The Notice of Hearing and Statement of Allegations, which set out the allegations, are available at:
    The violations occurred while Andrew Kazina conducted business in the Winnipeg, Manitoba area.

Orphan designation: Allogeneic cultured postnatal thymus-derived tissue Treatment of CHARGE syndrome, 26/02/2019 Positive

Retrieved on: 
Tuesday, April 9, 2024
Eurostat, Diagnosis, Civil service commission, Gene, Brain, Growth, Coloboma, Thymus, Patient, Committee, Knowledge, CHD7, Regulation, Child, Ventricular septal defect, EMA, IRIS, Eye, European, Infection, Therapy, COMP, Heart, Safety, European Commission, Spine, CHARGE syndrome, Nose, Genetic disorder, Sleep, Hearing, Medicine, Pharmaceutical industry

Orphan designation: Allogeneic cultured postnatal thymus-derived tissue Treatment of CHARGE syndrome, 26/02/2019 Positive

Key Points: 


Orphan designation: Allogeneic cultured postnatal thymus-derived tissue Treatment of CHARGE syndrome, 26/02/2019 Positive

Golden Sun Health Technology Group Limited Announces Receipt of Nasdaq Delisting Determination and Plan to Appeal

Retrieved on: 
Monday, March 25, 2024
Letter, Panel, Notice, Form, Security (finance), Calendar, Hearing, Cryptocurrency

According to the Letter, the Company had not regained compliance with the Minimum Bid Requirement as of March 20, 2024 and is not eligible for a second 180-day period.

Key Points: 
  • According to the Letter, the Company had not regained compliance with the Minimum Bid Requirement as of March 20, 2024 and is not eligible for a second 180-day period.
  • Specifically, the Company does not comply with the initial listing requirement of $5,000,000 minimum stockholders’ equity for The Nasdaq Capital Market, as contemplated for a second 180-day period.
  • The Company plans to appeal the Determination to the Panel in due course.
  • A hearing request will stay the suspension of the Company’s securities and the filing of Form 25-NSE pending the Panel’s decision.

Waldencast Regains Compliance with Nasdaq Filing Requirements

Retrieved on: 
Monday, March 25, 2024
WALD, Panel, Periodicity, Hearing

WHITE PLAINS, N.Y., March 25, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, announced that on March 21, 2024 the Company received formal notice from the Nasdaq Hearings Panel (the “Panel”) confirming that it has regained compliance with Nasdaq’s filing requirements, as set forth in Nasdaq Listing Rule 5250(c) (the “Periodic Filing Rule”) following the filing of the Company’s financial results for the interim period ended June 30, 2023 with the U.S. Securities and Exchange Commission.

Key Points: 
  • WHITE PLAINS, N.Y., March 25, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, announced that on March 21, 2024 the Company received formal notice from the Nasdaq Hearings Panel (the “Panel”) confirming that it has regained compliance with Nasdaq’s filing requirements, as set forth in Nasdaq Listing Rule 5250(c) (the “Periodic Filing Rule”) following the filing of the Company’s financial results for the interim period ended June 30, 2023 with the U.S. Securities and Exchange Commission.
  • In line with the applicable Nasdaq Listing Rules in such circumstances, the notice also indicated that Nasdaq had imposed a “Mandatory Panel Monitor” as that term is defined in Nasdaq Listing Rule 5815(d)(4)(B), for a period of one year from the date of the compliance determination (March 21, 2024), pursuant to which in the event the Company fails to timely satisfy the Periodic Filing Rule during the one-year monitor period, the Company will not have the opportunity to provide a compliance plan for the Nasdaq Listing Qualifications Staff’s review; rather, Nasdaq would instead issue a delist determination pursuant to which the Company could request a hearing and stay of the delist determination pending another hearing before the Panel.
  • Waldencast is proud to have accomplished this significant milestone and looks forward to providing further updates on its fiscal year 2023 performance in connection with the publication of its 2023 20-F.

LSV Advisors Acquires Controlling Interest in ClearCaptions from Reservoir Capital Group

Retrieved on: 
Monday, March 25, 2024
Senior, LSV, Acquisition, Hearing, Ageing, Management

ROSEVILLE, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- ClearCaptions , a leader in providing near real-time phone captioning services for the hard-of-hearing at no cost to eligible individuals, today announced that LSV Advisors has acquired a controlling interest in the company from funds managed by Reservoir Capital Group.

Key Points: 
  • ROSEVILLE, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- ClearCaptions , a leader in providing near real-time phone captioning services for the hard-of-hearing at no cost to eligible individuals, today announced that LSV Advisors has acquired a controlling interest in the company from funds managed by Reservoir Capital Group.
  • Investment from LSV Advisors will help enable ClearCaptions’ commitment to meeting the rising need through revolutionary assistive technology and unrivaled human support.
  • “The LSV Advisors acquisition of ClearCaptions highlights an exciting time in our company’s history that also marks an important moment for our future,” said Robert Rae, ClearCaptions CEO.
  • Investment from LSV Advisors will help bring this technology to new heights and create transformational change for those who need it most.

Venus Concept Granted Continued Listing from Nasdaq Hearings Panel, Subject to Return to Compliance with Nasdaq Listing Rules

Retrieved on: 
Monday, March 25, 2024
Venus, Plan, Panel, Hearing, Equity

On May 31, 2023, Nasdaq Listing Qualifications staff (“Nasdaq Staff”) issued the Company a deficiency notice citing that the stockholders’ equity as reported in the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2023, was below the minimum $2,500,000 required for continued listing under Nasdaq Listing Rule 5550(b)(1) (“Minimum Equity Requirement”).

Key Points: 
  • On May 31, 2023, Nasdaq Listing Qualifications staff (“Nasdaq Staff”) issued the Company a deficiency notice citing that the stockholders’ equity as reported in the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2023, was below the minimum $2,500,000 required for continued listing under Nasdaq Listing Rule 5550(b)(1) (“Minimum Equity Requirement”).
  • On July 17, 2023, the Company submitted to the Nasdaq Staff a plan to regain compliance with the Minimum Equity Requirement (the "Plan").
  • At the Hearing, the Company presented a comprehensive compliance plan to regain compliance to the Nasdaq Panel and received the Panel Decision regarding the Nasdaq Listing Rules on March 20, 2024.
  • “We are grateful for the opportunity from Nasdaq to continue to implement our turnaround plan, " said Rajiv De Silva, Chief Executive Officer of Venus Concept.